Prospective observational study to evaluate the utility of functional assessment scoring in patients with unresectable or advanced recurrent pancreatic cancer

Prospective observational study to evaluate the utility of functional assessment scoring in patients with unresectable or advanced recurrent pancreatic cancer - Prospective observational study to evaluate the utility of functional assessment scoring in patients with unresectable or advanced recurrent pancreatic cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000049890

Enrollment

100

Registered

2022-12-26

Start date

2022-03-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

unresectable or advanced recurrent pancreatic cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients with unresectable or recurrent pancreatic cancer who have been diagnosed as pancreatic cancer based on histological, imaging or clinical findings. 2) Patients who have been fully informed about the study and have given their written consent.

Exclusion criteria

Exclusion criteria: 1) Patients who are deemed by the treating doctor to be unsuitable for enrollment in this study. 2) Patients with pathologically diagnosed neuroendocrine tumor.

Design outcomes

Primary

Measure	Time frame
Functional assessment scoring and regimen selection, association with tolerability, and possible prognostic factors	—

Secondary

Measure	Time frame
Association of inflammatory and immune markers and body composition assessment with prognosis	—

Countries

Japan

Contacts

Public ContactKaori Hino

National Hospital Organization Shikoku Cancer Center Department of Gastrointestinal Medical Oncology

hino.kaori.mw@mail.hosp.go.jp0899991111

Outcome results